These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24269477)

  • 1. Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors.
    Kilianski A; Baker SC
    Antiviral Res; 2014 Jan; 101():105-12. PubMed ID: 24269477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.
    Zhao G; Du L; Ma C; Li Y; Li L; Poon VK; Wang L; Yu F; Zheng BJ; Jiang S; Zhou Y
    Virol J; 2013 Aug; 10():266. PubMed ID: 23978242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.
    Shen L; Niu J; Wang C; Huang B; Wang W; Zhu N; Deng Y; Wang H; Ye F; Cen S; Tan W
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors.
    Kilianski A; Mielech AM; Deng X; Baker SC
    J Virol; 2013 Nov; 87(21):11955-62. PubMed ID: 23986593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment.
    Li P; Kim Y; Dampalla CS; Nhat Nguyen H; Meyerholz DK; Johnson DK; Lovell S; Groutas WC; Perlman S; Chang K-O
    mBio; 2024 Feb; 15(2):e0287823. PubMed ID: 38126789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drugs specific for coronaviruses in preclinical development.
    Adedeji AO; Sarafianos SG
    Curr Opin Virol; 2014 Oct; 8():45-53. PubMed ID: 24997250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study.
    Berry M; Fielding BC; Gamieldien J
    Viruses; 2015 Dec; 7(12):6642-60. PubMed ID: 26694449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses.
    Hilgenfeld R; Peiris M
    Antiviral Res; 2013 Oct; 100(1):286-95. PubMed ID: 24012996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
    Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
    Sheahan TP; Sims AC; Graham RL; Menachery VD; Gralinski LE; Case JB; Leist SR; Pyrc K; Feng JY; Trantcheva I; Bannister R; Park Y; Babusis D; Clarke MO; Mackman RL; Spahn JE; Palmiotti CA; Siegel D; Ray AS; Cihlar T; Jordan R; Denison MR; Baric RS
    Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
    Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
    Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses.
    Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of A MERS-CoV Replicon Cell Line for Antiviral Screening.
    Chen J; Hu BJ; Zhao K; Luo Y; Lin HF; Shi ZL
    Virol Sin; 2021 Aug; 36(4):730-735. PubMed ID: 33616893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
    Weston S; Baracco L; Keller C; Matthews K; McGrath ME; Logue J; Liang J; Dyall J; Holbrook MR; Hensley LE; Jahrling PB; Yu W; MacKerell AD; Frieman MB
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30687-30698. PubMed ID: 33184176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative screening approaches for discovery of Middle East respiratory syndrome coronavirus inhibitors.
    LaFemina RL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4251-2. PubMed ID: 24867994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
    Sisk JM; Frieman MB; Machamer CE
    J Gen Virol; 2018 May; 99(5):619-630. PubMed ID: 29557770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular arms race between host innate antiviral response and emerging human coronaviruses.
    Wong LY; Lui PY; Jin DY
    Virol Sin; 2016 Feb; 31(1):12-23. PubMed ID: 26786772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment.
    de Wilde AH; Raj VS; Oudshoorn D; Bestebroer TM; van Nieuwkoop S; Limpens RWAL; Posthuma CC; van der Meer Y; Bárcena M; Haagmans BL; Snijder EJ; van den Hoogen BG
    J Gen Virol; 2013 Aug; 94(Pt 8):1749-1760. PubMed ID: 23620378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.
    Gallucci L; Bazire J; Davidson AD; Shytaj IL
    Antiviral Res; 2024 Jan; 221():105766. PubMed ID: 38042417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.